Showing results (21-30 of 59) with videos related to

Sort By:
Pageof 6
Journal of the American Chemical Society|October 24, 2002
Synthesis and evaluation of iron chelators with masked hydrophilic moietiesMichael M Meijler, Rina Arad-Yellin, Z Ioav Cabantchik, et al.
Blood|May 25, 2004
Labile plasma iron (LPI) as an indicator of chelatable plasma redox activity in iron-overloaded beta-thalassemia/HbE patients treated with an oral chelatorPensri Pootrakul, William Breuer, Matias Sametband, et al.
Blood|October 3, 2021
Hemochromatosis classification: update and recommendations by the BIOIRON SocietyDomenico Girelli, Fabiana Busti, Pierre Brissot, et al.
Biological Research|April 25, 2006
Characterization of mitochondrial iron uptake in HepG2 cellsDora Inés Mazariegos, Z Ioav Cabantchik, Bruce K Cassels, et al.
Blood|June 14, 2003
Labile plasma iron in iron overload: redox activity and susceptibility to chelationBreno P Esposito, William Breuer, Pornpan Sirankapracha, et al.
Blood|January 4, 2003
Effects of combined chelation treatment with pyridoxal isonicotinoyl hydrazone analogs and deferoxamine in hypertransfused rats and in iron-loaded rat heart cellsGabriela Link, Prem Ponka, Abraham M Konijn, et al.
British Journal of Pharmacology|November 25, 2010
Rescuing iron-overloaded macrophages by conservative relocation of the accumulated metalYang-Sung Sohn, Anna-Maria Mitterstiller, William Breuer, et al.
Plos One|November 13, 2014
Iron overload and apoptosis of HL-1 cardiomyocytes: effects of calcium channel blockadeMei-pian Chen, Z Ioav Cabantchik, Shing Chan, et al.
Haematologica|December 20, 2011
The role of endocytic pathways in cellular uptake of plasma non-transferrin ironYang-Sung Sohn, Hussam Ghoti, William Breuer, et al.
Leukemia Research|July 10, 2010
Prospective assessment of effects on iron-overload parameters of deferasirox therapy in patients with myelodysplastic syndromesPeter L Greenberg, Charles A Koller, Z Ioav Cabantchik, et al.
Pageof 6